Everything below concerns receptor agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Quality control for peptide material focuses on identity, purity, content and the profile of impurities. Common degradants include deamidated and oxidised forms, plus aggregates formed during storage or handling. Forced degradation studies under heat, light, acid and peroxide help define which conditions accelerate change and which analytical methods detect it. Limits for individual impurities are set by pharmacopoeial monographs or manufacturer specifications. How much a given impurity affects biological activity is often uncertain, and conclusions may depend on the assay used.
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
Reversed-phase high-performance liquid chromatography is widely used to assess purity and to separate the parent peptide from related substances. Mass spectrometry confirms identity and can resolve modifications that differ by a few daltons. Size-exclusion chromatography detects dimers and higher aggregates, which are relevant to both stability and immunogenicity questions. Peptide mapping with enzymatic digestion locates specific modifications along the sequence. Circular dichroism provides a secondary-structure profile, although it gives limited information about local conformational changes.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | 31 amino acid residues |
| Molecular formula | C187H291N45O59 | free peptide, no counter-ion |
| Approximate mass | 4114 Da | matches theoretical value |
| Receptor target | Glucagon-like peptide-1 receptor | Gs-coupled, cyclic AMP pathway |
| Circulation half-life | About one week in humans | extended by albumin association |
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
纯度评价多采用反相高效液相色谱，流动相常加入三氟乙酸或甲酸作为离子对改性剂，检测波长设在二百一十四纳米或二百二十纳米。分子量确认依靠电喷雾电离质谱或基质辅助激光解吸电离质谱，实测值应与理论值在数 ppm 内吻合。肽图分析通过酶切后液相色谱串联质谱完成，用于核查序列与修饰位点。体积排阻色谱用于定量共价与非共价聚集体。生物基质浓度测定则采用免疫分析或液相色谱串联质谱。
肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
Americium has been produced in small quantities in nuclear reactors for decades, and kilograms of its 241Am and 243Am isotopes have been accumulated by now. Nevertheless, since it was first offered for sale in 1962, its price, about US$1,500 per gram (US$43,000/oz) of 241Am, remains almost unchanged owing to the very complex separation procedure. The heavier isotope 243Am is produced in much smaller amounts; it is thus more difficult to separate, resulting in a higher cost of the order US$100,000–US$160,000 per gram (US$2,800,000–US$4,500,000/oz). Americium is not synthesized directly from uranium – the most common reactor material – but from the plutonium isotope 239Pu. The latter needs to be produced first, according to the following nuclear process:
Around 1500 BCE a tribe called the Oenotri ("vine-cultivators"), settled in the region. Ancient sources state they were Greeks who were led to the region by their king, Oenotrus. However it is more likely they were an ancient Italic people who spoke an Italic language. During the eighth and seventh centuries BCE, Greeks founded many settlements on the coast of southern Italy. In Calabria they founded Chone (Pallagorio), Cosentia (Cosenza), Clampetia (Amantea), Scyllaeum (Scilla), Sybaris (Sibari), Hipponion (Vibo Valentia), Epizephyrian Locris (Locri), Kaulon (Monasterace), Krimisa (Cirò Marina), Kroton (Crotone), Laüs (comune of Santa Maria del Cedro), Medma (Rosarno), Metauros (Gioia Tauro), Petelia (Strongoli), Rhégion (Reggio Calabria), Scylletium (Borgia), Temesa (Campora San Giovanni), Terina (Nocera Terinese), Pandosia (Acri) and Thurii, (Thurio, comune of Corigliano Calabro). In the year 744 BCE a group of Chalcidian settlers founded Rhegion (today Reggio Calabria) at the southern end of the peninsula. Soon after, other Chalcidans founded Zancle (current Messina) on the other side of the strait, securing their dominion over that arm of the sea. Later Chalcidian settlers from Rhegion and Zancle founded Metauros (Gioia Tauro) and divided the river of the same name (today Petrace) from the Italic city of the Tauri. In 710 BCE Ionian colonists founded Sybaris on the fertile plain of the same name at the mouth of the Crati.
==== Eva Kaili ==== Kaili denied any wrongdoing in the controversy. Her lawyers appeared on Greek TV stating that she "declares her innocence and that she has nothing to do with bribery from Qatar". Kaili's lawyers were also critical of her arrest as a "gross overreach of judicial power". They maintain that Kaili was in a state of shock, fear and confusion during her first interview and that she was not provided with an interpreter for the interview. According to her lawyers, it took a week for Kaili to be in "good enough psychological condition to be fully aware of what she was saying". Kaili reportedly felt "very troubled" and betrayed by her partner, Giorgi, according to her lawyers. Kaili has accused the Belgian authorities of "inhuman" behavior due to the Belgian authorities refusal to allow her to see her daughter in person or via Skype. Kaili said: "I am being tortured, this is so unfair that I cannot stand it, and I am breaking down. What is the problem with my little girl, why are they keeping her away from me?". The following day a three-hour meeting between Kaili and her daughter was authorised. The court decided on 16 February 2023 to keep Kaili in detention for another two months. Kaili had changed her Belgian lawyer from André Risopoulo to Sven Mary some time before the hearing. Mary had "represented one of the terrorists behind the 2015 Paris attacks". Kaili was released from pre-trial detention with an electronic bracelet on 14 April 2023 and, throughout the process, has continued to deny all charges against her.
== Financial assistance == In the Union Budget for 2019–20, the Finance Minister announced ₹804.75 crore (equivalent to ₹10 billion or US$110 million in 2026) to incentivize and promote processing in the fisheries sector for the Financial year 2019–20 through the newly formed Ministry of Fisheries, Animal Husbandry and Dairying. During the Budget speech, the finance minister asserted: "fishing and fishermen communities are closely aligned with farming and are crucial to rural India." The Economic Survey of India for the year 2018–19 had stressed on allied sectors and focused mainly on enhancing rural economy by strengthening Animal husbandry and Fisheries. Apart from this, the government had earlier set aside ₹7,552 crore (equivalent to ₹97 billion or US$1.0 billion in 2026) in the Fisheries and Aquaculture Infrastructure Development Fund (FIDF), which was intended to be utilized in creating both inland and overseas fishery infrastructure in the country. The government had set a target of 20 tonnes for fish production through the Blue Revolution by 2022–23. While announcing the stimulus package in the backdrop of the economic slowdown caused by the recent COVID-19 pandemic in India, the Finance Minister announced ₹20,000 crore (equivalent to ₹260 billion or US$2.7 billion in 2026) outlay to enhance the inland fisheries through Matsya Sampada Yojana.
Most navies prohibited women from serving on submarines, even after they had been permitted to serve on surface warships. The Royal Norwegian Navy became the first navy to allow women on its submarine crews in 1985. The Royal Danish Navy allowed female submariners in 1988. Others followed suit including the Swedish Navy (1989), the Royal Australian Navy (1998), the Spanish Navy (1999), the German Navy (2001) and the Canadian Navy (2002). In 1995, Solveig Krey of the Royal Norwegian Navy became the first female officer to assume command on a military submarine, HNoMS Kobben. On 8 December 2011, British Defence Secretary Philip Hammond announced that the UK's ban on women in submarines was to be lifted from 2013. Previously there were fears that women were more at risk from a build-up of carbon dioxide in the submarine. But a study showed no medical reason to exclude women, though pregnant women would still be excluded. Similar dangers to the pregnant woman and her fetus barred women from submarine service in Sweden in 1983, when all other positions were made available for them in the Swedish Navy. Today, pregnant women are still not allowed to serve on submarines in Sweden. However, the policymakers thought that it was discriminatory with a general ban and demanded that women should be tried on their individual merits and have their suitability evaluated and compared to other candidates. Further, they noted that a woman complying with such high demands is unlikely to become pregnant. In May 2014, three women became the RN's first female submariners.
Sources: en.wikipedia.org
=== Surface Tension Uncut and On a Rail Uncut === In Surface Tension Uncut, the "Surface Tension" chapter was expanded to include certain areas of the original game that were not released along with the remake, as the developer had left before his work was finished. The developer, Chon Kemp, known on the Black Mesa: Community Forums by the pseudonym TextFAMGUY1, also modified the "On a Rail" chapter to include the areas cut from Black Mesa to make gameplay less tedious. Kemp was later hired by Crowbar Collective to remake Surface Tension Uncut for the Steam release, while the uncut version of "On a Rail" was published on the Steam Workshop.
== Battery designs and formats == Lithium-ion batteries may have multiple levels of structure. Small batteries consist of a single battery cell. Larger batteries connect cells in parallel into a module and connect modules in series and parallel into a pack. Multiple packs may be connected in series to increase the voltage. Batteries may be equipped with temperature sensors, heating/cooling systems, voltage regulator circuits, voltage taps, and charge-state monitors. These components address safety risks like overheating and short circuiting.
==== Invasion preparedness ==== The Greenlandic government has asked citizens to prepare for a possible attack on Greenland by the United States, including by stockpiling supplies. According to a report by Danish broadcaster DR, published in March 2026, Danish forces also prepared defensive measures in early 2026, including the deployment of special forces units and the pre-positioning of medical supplies such as blood for potential casualties. Troops reportedly brought explosives intended to disable key airstrips in Nuuk and Kangerlussuaq to prevent American landings.
In April 2015, Hardee's announced the opening of its 300th restaurant in the Middle East with longtime franchisee, The Americana Group. In 2015, Nation's Restaurant News ranked Hardee's as the No. 28 foodservice chain by sales in the United States through 2011. Carl's Jr. was ranked at No. 37. Combined sales would rank the two at No. 15. In 2013, QSR listed Hardee's at No. 20 and Carl's Jr. at No. 24; if combined they would have been listed at No. 14. In July 2015, Hardee's announced that it would be offering The All-Natural Burger, which launched at sister-chain Carl's Jr. restaurants in December 2014. As of March 2016, CKE has a total of 3,664 franchised or company-operated restaurants in 44 states and 37 foreign countries and U.S. territories. The Hardee's in Millvale, Pennsylvania closed suddenly on August 25, 2025, after 52 years, marking the withdrawal of Hardee's from Greater Pittsburgh. Hardee's, which had entered Pennsylvania with the Sandy's purchase a year before the Millvale location opened, retains one location in Western Pennsylvania in Waynesburg (near the West Virginia border) while the rest in Pennsylvania are in South Central Pennsylvania. In 2026, Hardee's franchise operator Boddie-Noell announced that a location in Virginia Beach would close and be converted to a concept called Biscuits & Bird that focused on breakfast biscuits and chicken tenders, with the restaurant opening under the new branding in July 2026. On July 9, 2026, Superior Star LLC, a Phoenix-based Hardee's franchisee operating in the Midwest, filed for Chapter 11 bankruptcy protection.
The Wagler's pit viper is found in southern Vietnam from the provinces of Minh Hai and Song Be, in southern Thailand recorded from the provinces of Phang Nga, Phuket, Pattani, Surat Thani, Nakhon Si Tammarat, Narathiwat, and Yala, probably distributed throughout the Peninsula in west Malaysia, as well as the island of Penang, in Singapore and in Indonesia on Sumatra, the islands of the Riau Archipelago, Bangka, Billiton, Nias, the Mentawai Islands (Siberut), Natuna, and Karimata. In a revision by Vogel et al (2007), the Wagler's pit viper species complex was differentiated into several taxa, including the resurrection of T. subannulatus. The Western Philippine populations belong to T. subannulatus, but those from Mindanao include snakes assigned to both this species and T. philippensis. Tropidolaemus subannulatus has a wide distribution in Central Indonesia, Malaysia and Philippines, the Wagler's Pit Viper is restricted to mainland Southeast Asia, down to Sumatra and Bangka, West Indonesia."
Sources: en.wikipedia.org
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.
The substitution at position 8 removes the site recognised by dipeptidyl peptidase-4, the enzyme that destroys the native hormone within minutes. The linked lipophilic chain then binds circulating albumin, which further limits access by degradative enzymes and reduces renal loss. Together these features lengthen the effective circulation time considerably.
It acts at the glucagon-like peptide-1 receptor, a G protein-coupled receptor that signals mainly through cyclic AMP. Activation is glucose dependent, meaning insulin release is stimulated more strongly when blood glucose is already elevated. Other tissues carrying the same receptor respond as well, which explains effects beyond glucose control.
Lower temperatures slow hydrolysis, oxidation and aggregation reactions that degrade the molecule over time. Lyophilised powder is more tolerant than solution, but both benefit from controlled conditions.